Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Mapatumumab [USAN:INN]
Description: A fully human IgG1 agonistic mAb that exclusively targets tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R1) which is overexpressed on the surface of many tumors. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Sep 2018